Optimizing late-stage cancer care
AIQ Global (aiq-solutions.com) earns a Brand Analyzer score of 65 out of 100, placing it in the Developing tier among Healthcare brands, Technology brands. Among 2305 Healthcare brands analyzed, AIQ Global ranks in the 32nd percentile (category average 68, leader 95). The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark. Dimension scores: Name Quality 83/100, Digital Presence 82/100, Visual Identity 96/100, Messaging Clarity 100/100, Trust Foundation 63/100, AI Discoverability 37/100, Brand Authority 20/100.
AIQ Global (aiq-solutions.com) is a healthcare technology company focused on optimizing late-stage cancer patient care through artificial intelligence. Its core offering, TRAQinform IQ Technology, addresses the challenge of individual lesions responding differently to therapy in late-stage cancer - a phase it describes as poorly served by existing screening, diagnosis, and early treatment solutions. The company positions itself as the only solution dedicated to optimizing late-stage cancer therapy response, targeting healthcare providers and their patients.
| Brand Name | AIQ Global |
|---|---|
| Domain | aiq-solutions.com |
| Industry | Healthcare, Technology |
| Main Competitors | Tempus AI (76/100), Flatiron Health, Radiology Partners, Varian Medical Systems, Intelerad |
Moz Domain Authority 30/100 vs category average 29 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "AIQ enables optimization of late-stage cancer patient care through advanced AI technology." (No meta description) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Social footprint: verified profiles on Facebook, LinkedIn, Instagram, YouTube, GitHub; no detected presence on X (Twitter) - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
AIQ Global scores 19/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
AIQ Global has a weak AI-visibility profile at 19/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (50/100) and its weakest is visibility (0/100). It benefits from open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, no strong Wikidata entry and a low Moz Domain Authority of 30/100.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
AIQ Global's main competitors include Tempus AI (76/100), Flatiron Health, Radiology Partners, Varian Medical Systems, Intelerad. These companies compete in the Healthcare space for similar customers, offering comparable products or services.
Sources: AIQ Global official site
AIQ Global and Tempus AI are competitors in Healthcare. Brand Analyzer scores AIQ Global at 65/100 and Tempus AI at 76/100. They target overlapping audiences; the right choice depends on your specific needs and priorities.
Sources: AIQ Global official site
Popular alternatives to AIQ Global include Tempus AI (76/100), Flatiron Health, Radiology Partners, Varian Medical Systems, Intelerad. Each is an established option in the Healthcare space; the best fit depends on your specific needs, budget, and required features.
Sources: AIQ Global official site
AIQ Global has low AI-search visibility, scoring 19/100 on Brand Analyzer's AI visibility composite (visibility 0, trust 22, recommendation 50). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: AIQ Global official site
AIQ Global offers TRAQinform IQ Technology, an AI-powered platform designed to optimize therapy response assessment for late-stage cancer patients. This technology is presented as a solution that fills a gap beyond conventional cancer care tools - specifically targeting the monitoring and optimization of how individual lesions respond to therapy during late-stage cancer treatment. No additional distinct products or services are described in the available information.
Sources: AIQ Global official site
AIQ Global applies advanced artificial intelligence technology to optimize care for late-stage cancer patients. Specifically, it addresses the clinical challenge that individual lesions within a patient can respond differently to cancer therapy. Through its TRAQinform IQ Technology, AIQ Global provides tools that go beyond conventional screening, diagnosis, and early treatment, enabling healthcare providers to better assess and respond to how late-stage cancer is progressing or responding at the individual lesion level.
Sources: AIQ Global official site
AIQ Global scores 50/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: AIQ Global official site
AIQ Global is a healthcare technology company that develops AI-based solutions for late-stage cancer care. It positions itself as the only solution dedicated specifically to optimizing late-stage cancer therapy response. Operating at the intersection of healthcare and technology, the company focuses on a phase of cancer care it characterizes as poorly served - after screening, diagnosis, and early treatment have been addressed - where individual lesions may respond differently to ongoing therapy.
Sources: AIQ Global official site
AIQ Global can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: AIQ Global official site
AIQ Global is known for its TRAQinform IQ Technology, which is designed to optimize late-stage cancer therapy response. The company is distinguished by its focus on a specific and underserved segment of oncology care - the late-stage phase - where individual lesions may respond differently to treatment. It positions this technology as uniquely capable of providing optimization insights that existing screening, diagnosis, and early-treatment tools do not address.
Sources: AIQ Global official site
AIQ Global's solutions are intended for healthcare providers treating late-stage cancer patients. This includes oncologists and other clinical professionals who require detailed, AI-driven insights into how individual lesions are responding to therapy. Indirectly, the company's technology is also aimed at benefiting the late-stage cancer patients themselves, who represent the end recipients of the optimized care that healthcare providers deliver using AIQ's tools.
Sources: AIQ Global official site
Ranked closest to AIQ Global: Adaptive Telehealth (65/100), Acorn Analytics (65/100), AMPAworks (65/100), Benchmark Senior Living (65/100).
A step up - brands to learn from: Zipari by mPulse (71/100), Zaina AI (71/100).
Category leader: Dassault Systèmes (95/100).